PUMA BIOTECHNOLOGY, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $20.4M | $104.4M | $43.0M |
| FY2014 | $45.7M | $162.8M | $38.5M |
| FY2015 | $33.8M | $239.8M | $31.6M |
| FY2016 | $43.0M | $252.8M | $194.5M |
| FY2017 | $112.2M | $165.5M | $81.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $20.4M | $104.4M | $43.0M |
| FY2014 | $45.7M | $162.8M | $38.5M |
| FY2015 | $33.8M | $239.8M | $31.6M |
| FY2016 | $43.0M | $252.8M | $194.5M |
| FY2017 | $112.2M | $165.5M | $81.7M |